Kikuchi, Japan

Keiichi Makizumi



Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Kumamoto, JP (1991 - 2004)
  • Kikuchi, JP (2012)

Company Filing History:


Years Active: 1991-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Keiichi Makizumi: Innovator in Monoclonal Antibody Preparation

Introduction

Keiichi Makizumi is a prominent inventor based in Kikuchi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods for enhancing the efficacy of monoclonal antibody preparations. With a total of 4 patents to his name, Makizumi's work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents is a method for enhancing the efficacy of monoclonal antibody preparations. This innovative approach involves testing antigens from patients for their reactivity with the antibody. By deducing the amino acid sequence of an expressed protein from a nucleotide sequence obtained through the analysis of a target molecule gene in a biopsy, the method assesses the fitness of patients for the administration of monoclonal antibody preparations.

Another notable patent involves a novel MDCK-derived cell line (B-702) that can be grown in serum-free culture and suspension culture. This advancement allows for large-scale tank culture production without the need for fetal calf serum. Additionally, it provides a process for producing viruses for vaccines in a low-cost, highly safe, and stable manner.

Career Highlights

Keiichi Makizumi is associated with the Chemo-Sero-Therapeutic Research Institute, where he continues to innovate in the field of biotechnology. His work focuses on improving the safety and efficacy of medical treatments through advanced research and development.

Collaborations

Makizumi has collaborated with notable colleagues, including Yoichiro Kino and Sachio Tokiyoshi. Their combined expertise contributes to the advancement of research in monoclonal antibodies and vaccine production.

Conclusion

Keiichi Makizumi's contributions to biotechnology, particularly in monoclonal antibody preparation and vaccine production, highlight his role as an influential inventor. His innovative methods and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…